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Bacterial transcriptome analyses during host colonization are essential to decipher the
complexity of the relationship between the bacterium and its host. RNA sequencing
(RNA-seq) is a promising approach providing valuable information about bacterial
adaptation, the host response and, in some cases, mutual tolerance underlying
crosstalk, as recently observed in the context of Mycobacterium ulcerans infection.
Buruli ulcer is caused by M. ulcerans. This neglected disease is the third most common
mycobacterial disease worldwide. Without treatment, M. ulcerans provokes massive
skin ulcers. A healing process may be observed in 5% of Buruli ulcer patients several
months after the initiation of disease. This spontaneous healing process suggests that
some hosts can counteract the development of the lesions caused by M. ulcerans.
Deciphering the mechanisms involved in this process should open up new treatment
possibilities. To this end, we recently developed the first mouse model for studies of
the spontaneous healing process. We have shown that the healing process is based on
mutual tolerance between the bacterium and its host. In this context, RNA-seq seems to
be the most appropriate method for deciphering bacterial adaptation. However, due to
the low bacterial load in host tissues, the isolation of mycobacterial RNA from skin tissue
for RNA-seq analysis remains challenging. We developed a method for extracting and
purifying mycobacterial RNA whilst minimizing the amount of host RNA in the sample.
This approach was based on the extraction of bacterial RNA by a differential lysis
method. The challenge in the development of this method was the choice of a lysis
system favoring the removal of host RNA without damage to the bacterial cells. We
made use of the thick, resistant cell wall of M. ulcerans to achieve this end.
Keywords: RNA purification, RNA-seq, Mycobacterium ulcerans, cross-talk, host-bacteria interaction
Frontiers in Microbiology | www.frontiersin.org 1 March 2017 | Volume 8 | Article 512
fmicb-08-00512 March 22, 2017 Time: 16:29 # 2
Robbe-Saule et al. Isolation of Mycobacterium ulcerans RNA from Tissue
INTRODUCTION
RNA sequencing (RNA-seq), a next-generation sequencing
technique, opens up unique opportunities for deciphering
interactions between microorganisms and their hosts. It provides
information about the relative levels of expression of the various
genes and support for proteomic results. RNA-seq can also be
used to identify the regulatory networks controlled by non-
coding RNA, as reported for Mycobacterium tuberculosis (Arnvig
et al., 2011).
RNA sequencing can be used to investigate and characterize
the different facets of bacterial life, including, in particular, the
host/microorganism tolerance underlying crosstalk between the
two species (La et al., 2008; Skvortsov and Azhikina, 2010;
Westermann et al., 2012; Nalpas et al., 2013; Szafranska et al.,
2014; Amorim-Vaz et al., 2015). In this context, M. ulcerans
is a fascinating microorganism, with a complex biology due to
the different facets of its life cycle. M. ulcerans is the causal
agent of Buruli ulcer, a severe cutaneous infection (Vincent
et al., 2014) and the third most frequent mycobacterial disease
worldwide, after tuberculosis and leprosy (Asiedu et al., 2000).
M. ulcerans has developed sophisticated strategies for colonizing
various hosts, from aquatic organisms (aquatic plants, insects,
etc.) to humans, suggesting a “parasite lifestyle” (Portaels et al.,
1999, 2001; Marsollier et al., 2002, 2004, 2005, 2007a,b; Johnson
et al., 2007; Merritt et al., 2010; Garchitorena et al., 2014, 2015;
Marion et al., 2014a, 2016a; Zogo et al., 2015; Sanhueza et al.,
2016).
Mycobacterium ulcerans colonizes human tissues in several
phases. Following the inoculation of the dermis with M. ulcerans,
there is an intracellular phase of infection, in which the bacterium
remains within macrophages and neutrophils, allowing it to
evade immune system recognition (Torrado et al., 2007).
M. ulcerans then kills the host macrophage by producing
mycolactone, a lipid toxin, initiating an extracellular stage, in
which local mycolactone concentrations increase considerably,
leading to massive host tissue destruction. During these two
stages, mycolactone is not only cytotoxic, it also modulates the
immune system, modifying cytokine production and acting on
the peripheral nervous system to induce the formation of a
painless lesion (George et al., 1999; Coutanceau et al., 2005;
Oliveira et al., 2005; Torrado et al., 2007, 2010; Silva et al., 2009;
Fraga et al., 2010, 2012; Marion et al., 2014b). These pleiotropic
effects of mycolactone facilitate host colonization by this bacillus.
This toxin is a distinctive feature of M. ulcerans and seems to play
a key role in its eco-epidemiology and pathogenesis.
We recently showed that 5% of Buruli ulcer patients display
spontaneous healing without treatment (Marion et al., 2016a).
This clinically relevant observation demonstrates that patients
can develop responses that counteract the effects of M. ulcerans
and its toxin. Deciphering the mechanisms involved in this
process will open up new therapeutic strategies.
We have developed the first dedicated mouse model for
studies of the spontaneous healing process (Marion et al.,
2016b). During the characterization of this model, we made
an interesting discovery concerning the dynamics of viable
bacterial load in healed tissues: the load of cultivable bacilli was
found to be both high and stable in the long term (Marion
et al., 2016b). We then demonstrated that mycolactone synthesis
was inhibited in healed tissues. Surprisingly, transcriptomic
studies based on RT-qPCR showed that the bacteria in these
tissues were not dormant. Paradoxically, transcription levels for
the principal genes involved directly in toxin synthesis were
unaffected, suggesting that mycolactone synthesis was regulated
upstream, as already shown in vitro (Deshayes et al., 2013). Our
previous findings suggest that RNA-seq is the most appropriate
approach for deciphering the regulation of mycolactone synthesis
in vivo.
This approach requires the isolation of large amounts of high-
quality bacterial RNA, which is challenging in studies performed
in vivo, because host RNA is much more abundant than bacterial
RNA in samples. It was therefore necessary to optimize the
method for extracting RNA from tissues, so as to minimize the
amount of host RNA in the sample whilst ensuring the isolation
of sufficient quantities of high-quality mycobacterial RNA. We
present here this optimized method, based on differential lysis for
the analysis of the whole transcriptome of M. ulcerans.
MATERIALS AND METHODS
Ethics Statement for Animal Experiments
All animal experiments were performed in accordance with
national guidelines (articles R214–87 to R214–90 from the French
“rural code”) and European guidelines (directive 2010/63/EU of
the European Parliament and of the council of September 22,
2010 on the protection of animals used for scientific purposes).
All protocols were approved by the ethics committee of the Pays
de la Loire region, under protocol nos. CEEA 2009.14 and CEEA
2012.145, and performed at the required biosafety level. Animals
were maintained under specific pathogen-free conditions in the
animal house facility of Angers University Hospital, France
(agreement A 49 007 002).
Bacterial Strains and Inoculation
Mycobacterium ulcerans strain 01G897 was originally isolated
from patients from French Guiana (De Gentile et al., 1992).
Bacterial suspensions were prepared as previously described
(Marsollier et al., 2007b; Marion et al., 2016b), with adjustment
to 2× 105 acid-fast bacilli/ml for inoculation (50 µl) into the tail
of 6-week-old females of the inbred FVB/N mouse strain (Charles
River Laboratories, Saint-Germain-Nuelles, France).
RNA Extraction and Purification
RNA was extracted from infected tail skins 30 days post-infection,
by the Trizol/chloroform method (Method 1), which co-extracts
host and bacterial RNA, or by the differential lysis method
(Method 2), optimized and adapted from that described by
(Rustad et al., 2009), for the isolation of bacterial RNA alone.
Method 1: Total RNA Extraction
(i) Sample preparation: Tail skin was excised from infected
mice and immediately placed in a Petri dish containing a
mixture of 1 ml Trizol (Ambion) and 1 ml RLT buffer (Qiagen)
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supplemented with 1% β-mercaptoethanol. Skin tissues were cut
into smaller pieces, transferred to round-bottomed tubes and
broken up with a TissueRuptor (Qiagen).
(ii) RNA extraction and purification: Samples were
transferred to two bead beating tubes (0.1 mm glass beads,
MoBio) and were shaken with TissueLyser (Qiagen) at 4◦C for
5 min at 30 Hz. The samples were immediately placed on ice and
centrifuged at 10,000 × g for 5 min at 4◦C to remove cell debris.
The supernatant was transferred to a 15 ml tube containing
1 ml Trizol. 200 µl chloroform/isoamyl alcohol (24:1) was added
to the tube, which was then repeatedly inverted to mix and
centrifuged at 10,000 × g for 5 min. The aqueous phase was
transferred to a clean tube containing 400 µl chloroform/isoamyl
alcohol and centrifuged again, as in the previous step. The
aqueous phase was transferred to a clean tube containing
1 volume of 70% ethanol, and the tube was repeatedly gently
inverted to mix. Total RNA was purified with the RNeasy Midi kit
(Qiagen), with DNase treatment, according to the manufacturer’s
protocol, and eluted in 100 µl RNase- and DNase-free water.
(iii) DNase treatment: Contaminating DNA was removed by
retreating the RNA with DNase, for 45 min at 37◦C, with the
TURBO DNA-free kit (Ambion), according to the manufacturer’s
protocol.
(iv) Eukaryotic RNA removal: To reduce the levels of
contaminating host RNA from the samples, MICROBEnrich kit
(Ambion) was used according to the manufacturer’s protocol.
Method 2: Bacterial RNA Isolation by
Differential Lysis Method
(i) Sample preparation: Tail skin was excised from infected mice
and immediately placed in a Petri dish containing 2 ml Tris-
EDTA (TE) buffer (10 mM Tris-HCl, 1 mM EDTA). Skin tissues
were cut into smaller pieces, transferred to round-bottomed tubes
and broken up with a TissueRuptor (Qiagen). 4 ml TE buffer was
added and the tissue homogenates were digested with 1 ml of
a 20 mg/ml proteinase K solution (Qiagen) for 10 min at 55◦C
(without shaking). Another 6 ml of TE buffer was added and
the samples were centrifuged at 3,200 × g for 15 min at 4◦C.
The pellet, which contained the bacterial cells, was resuspended
in 300 µl Tri-reagent (Zymo Research) and 300 µl RLT buffer
(Qiagen) supplemented with 1% β-mercaptoethanol.
(ii) RNA extraction and purification: The samples were
transferred into a bead beating tube (0.1 mm glass beads,
MoBio) and shaken with TissueLyser (Qiagen) at 4◦C for
5 min at 30 Hz. The samples were immediately placed on ice
and centrifuged at 10,000 × g for 5 min at 4◦C to remove
cell debris. The supernatant was transferred into a clean tube
containing 1 volume of 100% ethanol, with which it was mixed by
repeated gentle inversion. The RNA was purified and treated with
DNase with the Direct-zol RNA MiniPrep kit (Zymo Research),
according to the manufacturer’s protocol, and eluted in 50 µl of
RNase- and DNase-free water.
(iii) DNase treatment: Contaminating DNA was removed by
retreating the RNA with DNase for 45 min at 37◦C with the
TURBO DNA-free kit (Ambion), according to the manufacturer’s
protocol.
RNA Analysis
(i) Quantification and purity analysis: Total RNA concentration
and purity (A260nm/A280nm) were assessed with 1 µl of the
RNA preparation, on a NanoDrop 1000TM (Thermo Scientific)
spectrophotometer. A ratio greater than 1.8 is usually considered
to indicate satisfactory RNA purity (Imbeaud et al., 2005).
(ii) Quality and integrity analysis: RNA quality and integrity
were assessed with the Experion automated electrophoresis
system (Bio-Rad). The total RNA sample (Method 1) was
diluted 10-fold and the Experion RNA StdSens analysis chip
was used (quantification of 5–500 ng/µl RNA). With enriched
bacterial RNA preparations (Method 2), the RNA was diluted
twofold and the Experion RNA HighSens analysis chip was
used (quantification of 100–5,000 pg/µl RNA). The RNA quality
indicator (RQI) method returns a number between 1 (highly
degraded RNA) and 10 (intact RNA) for each RNA sample
(Imbeaud et al., 2005; Schroeder et al., 2006).
Transcriptional Analysis by RT-qPCR
RT-qPCR targeting the M. ulcerans ppk gene was performed
to detect mycobacterial RNA transcripts in RNA samples. RT-
qPCR targeting the mouse gapdh gene was performed to evaluate
the contamination of RNA samples with host RNA. The ppk
and gapdh genes were selected as housekeeping genes for the
RT-qPCR analyses for M. ulcerans and mouse, respectively.
Amplification efficiency (Table 1) was determined from the slope
of a standard curve of cDNA serial dilutions.
(i) Reverse transcription: The first-strand cDNA was
synthesized in a reaction volume of 20 µl containing 2 µl of total
RNA, 500 ng of random primers (Invitrogen) and the M-MLV
reverse transcriptase (Invitrogen). Contaminating DNA in RNA
sample was checked by performing a negative control with no
reverse transcriptase (RT-) for each sample.
(ii) Quantitative real-time PCR: qPCR was performed in a
reaction volume of 10 µl containing Absolute Blue qPCR mix
(Thermo Scientific), 300 nM primers, 100 nM Taqman probe
(Table 1) and 2.5µl of diluted twofold dilution of cDNA/RT-. The
sequences of the primers and probes used are provided in Table 1.
Reactions were run on a AriaMx Thermocycler (Agilent), with
the following program: 10 min at 95◦C and 40 cycles of 10 s at
95◦C and 1 min at 60◦C. Each sample was analyzed in duplicate.
RNA-Sequencing
(i) Ribosomal RNA (rRNA) removal: rRNA was depleted from
the mycobacterial total RNA preparations with the RiboZero
Epidemiology Illumina kit, which removes eukaryote and
prokaryote rRNA in a single step.
(ii) Preparation of RNA-seq libraries: The RNA-seq libraries
were prepared with the TruSeq Stranded Total RNA LT Sample
Prep kit (Illumina). The quality of all libraries was checked
with the DNA-1000 kit (Agilent) on a 2100 Bioanalyzer and
quantification was performed with Quant-It assays on a Qubit 1.0
fluorometer (Invitrogen).
(iii) RNA-seq: Clusters were generated for the resulting
libraries, with Illumina HiSeq SR Cluster Kit v4 reagents.
Sequencing was performed with the Illumina HiSeq 2500 system
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TABLE 1 | Primer/probe sequences.
Primer/probe Name Sequence (5′ to 3′) Efficiency (%) R2 Reference
MuPpk_Forward Polyphosphate kinase, MUL_1972, [M. ulcerans Agy99] CGGGAAACTACAACAGCAAGACC 96% 0.9997 This study
MuPpk_Reverse CCACCAACAGATTGCGATAGG
MuPpk_Probe CCGACATTGGCGCAGACCTCACC
GAPDH_Forward Glyceraldehyde-3-phosphate dehydrogenase, [Mouse] GTGGCAAAGTGGAGATTGTTG 97% 0.9999 This study
GAPDH_Reverse TGACAAGCTTCCCATTCTCG
GAPDH_Probe TCCACTCACGGCAAATTCAACGGCA
and HiSeq SBS kit v4 reagents. Runs were carried out over
65 cycles, including seven indexing cycles, to obtain 65-bp
single-end reads. Sequencing data were processed with Illumina
Pipeline software (Casava version 1.9). All 65-bp reads were
aligned against the complete genome and plasmid sequences of
M. ulcerans (Agy99 strain) obtained from the Burulist database
with Bowtie software, and against the mouse genome (GRCm38)
obtained from the Ensembl database with STAR software. Data
were normalized and analyzed in R, with the Bioconductor
packages.
RESULTS
We recently developed a model for studies of the spontaneous
healing process. Our studies in this model revealed that the
host response modulated toxin synthesis, providing evidence for
crosstalk between M. ulcerans and the host. We therefore decided
to develop a method for extracting bacterial RNA from host tissue
in conditions suitable for high-throughput RNA-seq, to make
it possible to decipher the regulation of toxin production. We
evaluated two methods for isolating M. ulcerans RNA from host
tissue (tail) for RNA-seq analysis. In this study, we inoculated
the tails of mice that were then killed for analysis 30 days
post-infection. All infected mice presented clinical edemas and
bacterial load was estimated at about 106 CFU (8.9 × 105–
2.1 × 106 CFU). Each of the RNA extraction methods was
evaluated on three samples (taken from three mice).
Method 1: Extraction of Total RNA from
Tail Skin Infected with M. ulcerans
For studies of the interactions between the host and the bacteria
during the infection of mice with M. ulcerans, we initially tried to
extract bacterial and host RNA together, from the tail skin of mice
infected with M. ulcerans. The infected tissues were broken up
with a TissueRuptor and subjected to chemical and mechanical
lysis, to release the bacterial and eukaryotic RNA. The RNA was
then subjected to Trizol/chloroform extraction and purified on a
Qiagen midi column which allows the purification of up to 1 mg
RNA (Figure 1).
With this approach, we obtained 200 to 300 µg of total RNA
per sample (Figure 2C). Electrophoretic analysis revealed strong
bands corresponding to the 18S and 28S rRNA of eukaryotic
cells, with no bacterial RNA bands corresponding to 16S and 23S
rRNA in samples (Figure 2A and Supplementary Figure S1).
The electropherogram trace confirmed this result, as it contained
peaks only for mouse rRNA (Figure 2B and Supplementary
Figure S1). The mycobacterial RNA transcripts in samples were
assessed by a reverse transcription-polymerase chain reaction
(RT-qPCR) targeting the M. ulcerans housekeeping gene, ppk.
The samples contained only small amounts of mycobacterial
RNA, with Ct values of 32–33 (Table 2). The A260nm/A280nm ratio
exceeded 1.8, confirming the purity of the RNA in each sample
(Figure 2C), and electrophoresis showed a complete absence of
RNA degradation, with an RQI value greater than 9 (Figure 2C).
However, we were unable to assess the integrity of bacterial RNA,
because no bacterial RNA was visualized.
To eliminate the host RNA from the samples, MICROBEnrich
kit (Ambion) was used which selectively removes 18S, 28S
rRNA, and polyadenylated mRNA. Following MICROBEnrich
treatment, electrophoresis was performed and showed this
treatment to have been poorly effective in our hands, because
strong bands corresponding to the 18S and 28S rRNAs were still
detected (Figure 2D). These data confirmed the predominance
of eukaryotic ribosomal RNA in samples, and suggested that
mouse mRNA would probably also predominate over bacterial
transcripts. However, based on our qPCR demonstrating the
presence of mycobacterial RNA in samples, we decided to attempt
a deep sequencing approach (RNA-seq) on a sample before
and after bacterial RNA enrichment with the MICROBEnrich
kit. The obtained RNA-seq data showed an absence of reads
aligned with the M. ulcerans genome, even though mycobacterial
RNA transcripts were detected by RT-qPCR, a more sensitive
technique. In this case, sequencing depth was insufficient to
obtain reads mapping to the M. ulcerans genome, confirming
that the removal of mouse RNA was not effective enough to
achieve an enrichment of the sample in mycobacterial RNA.
In conclusion, these data demonstrate that studies of the
M. ulcerans transcriptome in vivo will require a method capable
of significantly decreasing eukaryotic RNA levels, to facilitate the
detection of mycobacterial transcripts by RNA-seq.
Method 2: Bacterial RNA Isolation by the
Differential Lysis Method
We developed an alternative technique for the purification of
bacterial RNA from infected host tissues by differential lysis, to
achieve our goal. The principal challenge in this method was
the choice of a lysis system resulting in host-cell lysis without
damage to the bacterial cells. We recently demonstrated that
the mechanical disruption of tissues had no effect on bacterial
viability (Marion et al., 2016b). We therefore disrupted the host
cells by mechanical lysis and treated them with proteinase K, to
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FIGURE 1 | Scheme for total RNA extraction (Method 1) and comparison with the differential lysis method (Method 2).
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FIGURE 2 | Evaluation of the coextraction method (Method 1). (A) Image of the electrophoresis gel for three independent RNA samples extracted from mice
infected with M. ulcerans. L, RNA ladder. (B) Electropherogram: example of sample RNA derived from lane 1. (C) Table with RNA concentrations (ng/µl), indicator of
purity (ratio A260/A280), integrity of RNA samples (RQI, RNA Quality Indicator), and total quantity (µg) of RNA extracted with Method 1. (D) Electropherogram:
example of sample RNA before and after MicrobEnrich (ME) treatment. The 18S and 28S (mouse), and 16S and 23S (bacterial) rRNA bands are indicated in red and
green, respectively.
digest and degrade the mouse tissue whilst leaving the bacterial
cells intact. The intact bacterial cells were then separated from
the lysate containing host RNA by centrifugation, and the pellet
containing the bacteria was resuspended in lysis buffer and
subjected to bead beating. The bacterial RNA was purified on
a Zymo column, making it possible to purify up to 100 µg of
RNA directly from samples in Tri-reagent, a much less time-
consuming approach (Figure 1).
We obtained 150 to 500 ng of total RNA per sample
(Figure 3C), about one-thousandth the amount obtained with
Method 1 (Figure 2C). However, gel electrophoresis on the
total RNA obtained with this method revealed the presence of
bands corresponding to the 16S and 23S bacterial rRNA whereas
the mouse 28S and 18S rRNA were not detected (Figure 3A
and Supplementary Figure S1). This finding was confirmed
by the electropherogram trace (Figure 3B and Supplementary
Figure S1).
The enrichment of samples in mycobacterial RNA by the
differential lysis method (Method 2) was evaluated by RT-
qPCR. The efficacy of eukaryotic RNA removal during sample
preparation with Method 2 was evaluated by comparing
equivalent fractions of enriched (Method 2) and non-enriched
(Method 1) RNA samples. We quantified the expression of both
bacterial and mouse genes in the samples obtained with the two
methods.
No PCR product was obtained if the amplification was
performed without prior reverse transcription (RT-). There was
therefore no detectable DNA contamination. A comparison of
ppk transcription levels showed that the transcript of this gene
was present in both cases, with similar Ct values (30–33). An
analysis of murine gapdh gene transcription revealed a difference
in Ct of 15 between Method 1 and Method 2 (Table 2),
corresponding to the presence of five orders of magnitude less
host RNA with Method 2 than with Method 1. These results
clearly demonstrate the efficacy of Method 2 for removing
eukaryotic RNA. This method was, thus, considered suitable
for the enrichment of samples in M. ulcerans RNA. The purity
and integrity of bacterial RNA were assessed by determining
the A260nm/A280nm ratio and the RQI value, respectively. The
A260nm/A280nm ratio was greater than 1.8 (Figure 3C) and RQI
values ranged from 7.3 to 9 (Figure 3C), indicating that the RNA
was of sufficiently high quality for use in subsequent experiments,
including transcriptional analyses.
Given the promising nature of these findings, we performed
deep sequencing (RNA-seq) on the enriched samples. The
removal of rRNA is a crucial step in RNA-seq, because
TABLE 2 | Comparison of Ct values between the coextraction method (Method 1) and the differential lysis method (Method 2).
Ct values M1-1 M1-2 M1-3 M2-1 M2-2 M2-3
M. ulcerans ppk 33.6 32.4 32.7 30.3 30.7 31.5
Murine gapdh 17.7 17.5 17.1 33.3 32.5 32.8
The values correspond to the means of duplicates.
Frontiers in Microbiology | www.frontiersin.org 6 March 2017 | Volume 8 | Article 512
fmicb-08-00512 March 22, 2017 Time: 16:29 # 7
Robbe-Saule et al. Isolation of Mycobacterium ulcerans RNA from Tissue
FIGURE 3 | Evaluation of the differential lysis method (Method 2). (A) Image of the electrophoresis gel for three independent RNA samples extracted from
mice infected with M. ulcerans. L, RNA ladder. The 16S and 23S (bacterial) rRNA bands are indicated in green. (B) Electropherogram: example of sample RNA
derived from lane 3. (C) Table with RNA concentrations (ng/µl), indicator of purity (ratio A260/A280), integrity of RNA samples (RQI, RNA quality indicator), and total
quantity (ng) of RNA extracted with Method 2.
rRNA signals can prevent adequate coverage of the bacterial
transcriptome. We therefore used the Ribo-Zero gold rRNA
Removal Kit (Epidemiology, Epicentre) to remove both mouse
and bacterial rRNA before producing the cDNA library. The
RNA-seq data confirmed that less than 5% of the reads mapped
to rRNA, demonstrating the efficacy of the rRNA removal kit.
The datasets for samples M2-1, M2-2 and M2-3 obtained by
the optimized method (Method 2) contained 9.5, 7.6 and 7.9
million reads aligning with the M. ulcerans genome, respectively,
whereas no reads aligned with this genome sequence were
detected with the samples obtained by Method 1 (Figure 4). This
enrichment procedure therefore provides sufficient coverage of
sequences mapping to the M. ulcerans, because a minimum of
2 to 5 million reads from a ribosomal RNA-depleted library is
required to provide adequate coverage of the gene expression
profiles of bacteria in RNA-seq experiments (Rienksma et al.,
2015).
Finally, two biological replicates, M2-1 and M2-2, were used
to evaluate the reproducibility of the gene expression profiles
obtained with RNA-seq technology. Spearman’s coefficient of
correlation between samples (r = 0.9813) indicated a similar
overall pattern of relative gene expression in the biological
replicates, indicating that Method 2 was reproducible (Figure 5).
This optimized method can therefore be used to study the
mycobacterial transcriptome in a mouse model.
DISCUSSION
Over the last few years, RNA-seq has become a powerful tool
for studies of complex interactions between microorganisms
FIGURE 4 | Percentage of reads aligned with the M. ulcerans and
mouse genomes. M1, Total RNA sample obtained with Method 1; M1_ME,
Total RNA sample obtained with Method 1 after enrichment with
MICROBEnrich (ME); M2, Bacterial RNA-enriched sample obtained by
differential lysis (Method 2). M2-1, M2-2, M2-3 represent three replicates for
Method 2.
and their hosts (La et al., 2008; Skvortsov and Azhikina, 2010;
Westermann et al., 2012; Szafranska et al., 2014; Amorim-Vaz
et al., 2015). This method is highly suitable for studies aiming
to decipher the complexity of regulation during interactions
between host and bacteria.
RNA sequencing provides ready access to information about
the host response during the different phases of colonization
by the microorganism, but it is much more difficult to
investigate transcription patterns in the microorganism. This
is the principal reason for which most reports have focused
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FIGURE 5 | Reproducibility of Method 2 for gene expression profiles
obtained by RNA-seq. Two biological replicates (M2-1 and M2-2) prepared
with the same procedure (Method 2) were used to evaluate reproducibility in
Spearman’s correlation tests. Each dot corresponds to a single gene. The x
and y axes indicate the level of expression of a single gene in two different
samples (M2-1 and M2-2). Spearman’s correlation coefficient = 0.9813.
essentially on host gene expression (Jenner and Young, 2005;
Hossain et al., 2006; La et al., 2008). Bacterial transcriptomic
signatures are much less widely documented (Jansen and
Yu, 2006; La et al., 2008) because bacterial mRNA yields
are much lower than those for host RNA (Lucchini et al.,
2001; Hinton et al., 2004; Ferreira-Machado et al., 2015). It
is therefore necessary to overcome this technical difficulty
to decipher, through transcriptomic approaches, the basis of
microbial attack and the ways in which the microbe escapes host
defenses.
The spontaneous healing process observed during M. ulcerans
infection highlights the ability of the host to counteract the lesion
development caused by the bacterium. We recently developed
the first mouse model for investigating this phenomenon
(Marion et al., 2016b). Our investigations have revealed a
strong inhibition of mycolactone synthesis during spontaneous
healing. In conclusion, this model provides a unique opportunity
to understand the regulation of mycolactone synthesis and
to identify possible drug targets. To this end, RNA-seq
seems to be the most appropriate method. However, due
to the low bacterial load in host tissues, the isolation of
mycobacterial RNA from skin tissue for RNA-seq analysis
remains challenging.
In this context, we initially attempted to co-extract host and
bacterial RNA together, for studies of the total transcriptome
of M. ulcerans in vivo. This approach is hindered by a
technical issue for bacterial transcriptome analysis: lower yields
for bacterial RNA than for host RNA. The high abundance
of host RNA reduced the coverage of sequences mapping
to the M. ulcerans genome. Commercial kits, such as the
MicrobEnrich kit, have been developed to overcome this
problem, and these kits have been successfully used in some
studies (Bergman et al., 2007; Audia et al., 2008; Bielecki
et al., 2011; Date et al., 2014). However, in our context,
use of the MicrobEnrich kit did not provide a sufficiently
high level of enrichment in mycobacterial RNA, because no
mycobacterial transcripts were detected by RNA-seq. This may
reflect the large proportion of host RNA in sample. We
therefore developed an alternative method for studying the whole
transcriptome of M. ulcerans in vivo by RNA-seq, in which
mycobacterial enrichment was increased during the sample
preparation process.
This method is based on the extraction of bacterial RNA
by a differential lysis method. The principal challenge in this
method is the choice of a system capable of lysing the host cells
without damaging the bacterial cells. Chemical or mechanical
differential lysis methods are generally used for RNA isolation
in vivo (Schnappinger et al., 2003; Talaat et al., 2004, 2007;
Tuanyok et al., 2006). Our method took advantage of the thick,
resistant wall of M. ulcerans, which is generally considered
problematic for the extraction of RNA, DNA and proteins.
This resistance of the bacterial wall makes it possible (i)
to lyse eukaryotic cells without damaging M. ulcerans cells,
(ii) to remove large amounts of eukaryotic RNA by simple
centrifugation and, (iii) to obtain high-quality bacterial RNA for
RNA-seq analysis.
CONCLUSION
We have developed the first simple protocol for the selective
extraction of M. ulcerans RNA from host tissues. This method
represents a significant improvement as it provides RNA of
sufficiently high quality for RNA-seq analysis. This strategy
will make it possible to perform in vivo studies of the
interactions between mycobacteria and their host, improving
our understanding of the molecular mechanisms underlying
infection. Finally, it may be possible to adapt this method for
the isolation of other mycobacteria in the host colonization
context.
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